Buserelin Acetate CAS:68630-75-1

Buserelin, sold under the brand name Suprefact among others, is a medication which is used primarily in the treatment of prostate cancer and endometriosis.It is also used for other indications such as the treatment of premenopausal breast cancer, uterine fibroids, and early puberty, in assisted reproduction for female infertility, and as a part of transgender hormone therapy.In addition, buserelin adhibetur in VETERINARIUS medicine.The medicamen typice usus est ut a nasi imbre ter per diem, sed etiam in usu est ut solutio vel infundatur ad iniectionem in adipem.

Partes effectus buserelini referuntur ad privationem hormonum sexus et indicia includunt gradus testosteronis humilium et gradus estrogenorum sicut calidum fulgurum., sexuali distemperantia, vaginalis ATROPHIA, et osteoporosis.Buserelin est gonadotropin-hormona agonist (GnRH agonist) et operatur impediendo sexum hormonum productione per gonads. Sex hormonum gradus circa sexum demittere potest. 95% in utroque sexes.Buserelin est peptide et analogon GnRH.

Etilamide; QUAM-766; HOR-766A; ICI-123215; S-746766; D-Esse(tBu*)⁶EA¹⁰-LHRH; 6-[O*-(1,1-Dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide-LHRH (porcus)